Why Immutep Limited ADR (IMMP) Stock Is Rising
As of 2026-09-30, Immutep Limited ADR (IMMP) has a next-year EPS growth estimate of 25.46%. Featured in our EPS revision report on 2026-09-30.
Why IMMP Stock Is Rising
- ·Current-Year Growth: Projected at 81.03%, supporting the forward estimate revision.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 25.46%
- EPS growth this year
- 81.03%
- EPS next quarter (est)
- -$0.71
- Last price
- $4.71
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-09-30 | 25.46% | 81.03% | -$0.71 | $4.71 |
| 2026-09-29 | 25.46% | 81.03% | -$0.71 | $4.71 |
| 2026-09-28 | 25.46% | 81.03% | -$0.71 | $4.88 |
| 2026-09-27 | 25.46% | 81.03% | -$0.04 | $0.26 |
| 2026-09-01 | 55.66% | -10.49% | -$0.09 | $0.37 |
| 2026-08-31 | 55.66% | -10.49% | -$0.09 | $0.37 |
| 2026-08-30 | 54.98% | 11.82% | -$0.03 | $0.38 |
| 2026-08-29 | 54.98% | 11.82% | -$0.03 | $0.38 |
| 2026-08-28 | 54.98% | 11.82% | -$0.03 | $0.38 |
| 2026-08-27 | 54.98% | 11.82% | -$0.03 | $0.38 |
| 2026-08-26 | 54.98% | 11.82% | -$0.03 | $0.38 |
| 2026-08-25 | 54.98% | 11.82% | -$0.03 | $0.38 |
| 2026-08-24 | 54.98% | 11.82% | -$0.03 | $0.39 |
| 2026-08-23 | 54.98% | 11.82% | -$0.03 | $0.39 |
| 2026-08-21 | 54.98% | 11.82% | -$0.03 | $0.39 |
| 2026-08-20 | 54.98% | 11.82% | -$0.03 | $0.39 |
| 2026-08-19 | 54.98% | 11.82% | -$0.03 | $0.39 |
| 2026-08-18 | 54.98% | 11.82% | -$0.03 | $0.40 |
| 2026-08-17 | 54.98% | 11.82% | -$0.03 | $0.39 |
| 2026-08-16 | 54.98% | 11.82% | -$0.03 | $0.38 |
| 2026-08-14 | 54.98% | 11.82% | -$0.03 | $0.38 |
| 2026-08-13 | 54.98% | 11.82% | -$0.03 | $0.40 |
| 2026-08-12 | 54.98% | 11.82% | -$0.03 | $0.38 |
| 2026-08-11 | 54.98% | 11.82% | -$0.03 | $0.39 |
| 2026-08-10 | 54.98% | 11.82% | -$0.03 | $0.38 |
| 2026-08-09 | 54.98% | 11.82% | -$0.03 | $0.39 |
| 2026-08-07 | 54.98% | 11.82% | -$0.03 | $0.39 |
| 2026-08-06 | 54.98% | 11.82% | -$0.03 | $0.38 |
| 2026-08-05 | 54.98% | 11.82% | -$0.03 | $0.39 |
| 2026-08-04 | 54.98% | 11.82% | -$0.03 | $0.39 |
Reports Featuring IMMP
Recent News
- Change to American Depositary Share RatioGlobeNewswire
- Immutep Outlines Focused Development Strategy for Eftilagimod Alfa (efti)GlobeNewswire
- Lost Money on Immutep Limited (IMMP)? Possible Fraud - Contact Levi & Korsinsky TodayNewsfile
- Immutep Reports Progress from Phase I Study of LAG-3 Agonist for Autoimmune DiseasesGlobeNewswire
- Immuteps LAG-3 hopes take a hit on Phase III NSCLC terminationClinical Trials Arena
- Adobe downgraded, Nio upgraded: Wall Street's top analyst callsThe Fly
- TACTI-004 Phase III Study in First Line NSCLC to be discontinued following Futility AnalysisGlobeNewswire
- Evotec, Vistagen lay off staff; Immutep shares collapse on study failureBioPharma Dive
- Immutep Achieves 50% Enrolment in Global TACTI-004 (KEYNOTE-F91) Phase III Trial in 1L NSCLCGlobeNewswire
Screen Performance
Aggregate stats across all 2057 tickers our top-EPS-revision screen has flagged over the past 182 days.
- Median return since detection
- +0.0%
- % of tickers in the green
- 48%
- Median return on winners
- +23.5%
- Large revisions captured
- 1787
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Also Tracked by Our Screen
Frequently Asked Questions
Why did Immutep Limited ADR (IMMP) stock go up recently?▾
Immutep Limited ADR (IMMP) stock has risen following an analyst upgrade of its next-year EPS growth estimate on 2026-09-27. EPS estimate upgrades are among the strongest leading indicators of stock outperformance.
What is Immutep Limited ADR's next-year EPS growth estimate?▾
As of 2026-09-30, Immutep Limited ADR (IMMP) has a next-year EPS growth estimate of 25.46%, based on analyst consensus.
When was the latest EPS estimate revision for IMMP?▾
The most recent revision occurred on 2026-09-27, when analysts adjusted the next-year EPS growth estimate from 55.66% to 25.46%.
What sector and industry does Immutep Limited ADR belong to?▾
Immutep Limited ADR operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. IMMP appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Immutep Limited ADR (IMMP) appears here because it was detected by our daily top-EPS-revision-performer screen.